Results 31 to 40 of about 119,431 (261)

Clinical significance of galectin-3 expression in urinary bladder carcinoma

open access: yesJournal of International Medical Research, 2023
Objective To uncover the clinical significance of galectin-3 in the evolution of urinary bladder cancer by defining galectin-3 expression and examining the relationship between its expression in a group of urothelial carcinomas versus normal tissues ...
Jaudah Ahmed Al-Maghrabi   +1 more
doaj   +1 more source

A rare case of inflammatory myofibroblastic tumor of the bladder with local invasion of the cervix and right ovary

open access: yesUrology Case Reports, 2023
Inflammatory myofibroblastic tumors (IMT) are rare spindle cell neoplasms derived from mesenchymal cells. Primary genitourinary IMTs share morphological and molecular features with various malignant spindle cell sarcomas, which introduces a diagnostic ...
Lars Neuenschwander   +3 more
doaj   +1 more source

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
Recommendations for clinical and molecular identification of LS, surgical and endoscopic management of LS‐associated colorectal cancer and preventive measures for cancer were produced. The emphasis was on surgical and gastroenterological aspects of the cancer spectrum.
T. T. Seppälä   +18 more
wiley   +1 more source

Rare neuroendocrine tumor decades after bladder exstrophy repair with enterocystoplasty

open access: yesJournal of Pediatric Surgery Case Reports, 2018
Bladder exstrophy is associated with an increased risk of bladder cancer. Adenocarcinoma is the main histological type found in the bladder exstrophy, accounting for 95% of cases, whereas squamous cell carcinoma accounts for 3–5% cases.
Sabine Roux   +4 more
doaj   +1 more source

Tumor Markers (CEA, TPA and CA 19–9) in Urine of Bladder Cancer Patients

open access: yesThe International Journal of Biological Markers, 1987
This study was carried out to evaluate the usefulness of determining urinary levels of carcinoembryogenic antigen (CEA), tissue-polypeptide antigen (TPA), and gastrointestinal cancer antigen (Cal 9-9) in addition to the usual diagnostic procedures for ...
Alessandro Tizzani   +6 more
doaj   +1 more source

Multiple primary malignancies

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2017
Two cases of multiple primary malignancies (two or more neoplasms without any relationship between them) are presented in this paper. The first case (65 years) was a male in whom follicular carcinoma of thyroid, metachronous neuroendocrine tumor of ...
Dibanur Rashid Siddiqua   +3 more
doaj   +1 more source

A rare case of seminoma metastasis to the bladder

open access: yesВестник урологии
Introduction. The great majority of testis neoplasms are germ cell tumours. The most common site of metastasis is the retroperitoneal region. Metastasis to the bladder is very rare.Clinical case.
Muhamad Al-Tawil
doaj   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Solitary fibrous tumor of urinary bladder in a female patient and transurethral enucleation of tumor

open access: yesActa Medica Alanya, 2018
Solitary fibrous tumors are rare neoplasms, initially defined in visceral pleura. Recently, they have been noticed to have ubiquitous distribution of human body. Solitary fibrous tumor of bladder is extremely rare especially in the females.
Ali Akkoç   +2 more
doaj   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy